Iovance Biotherapeutics's Options: A Look at What the Big Money Is Thinking
Iovance Biotherapeutics's Options: A Look at What the Big Money Is Thinking
Whales with a lot of money to spend have taken a noticeably bearish stance on Iovance Biotherapeutics.
有很多錢可以花的鯨魚對Iovance Biotherapeutics採取了明顯的看跌立場。
Looking at options history for Iovance Biotherapeutics (NASDAQ:IOVA) we detected 17 trades.
從Iovance Biotherapeutics（納斯達克股票代碼：IOVA）的期權歷史來看，我們發現了17筆交易。
If we consider the specifics of each trade, it is accurate to state that 17% of the investors opened trades with bullish expectations and 82% with bearish.
如果我們考慮每筆交易的具體情況，可以準確地說，有17％的投資者以看漲的預期開盤，82％的投資者以看跌的預期開盤。
From the overall spotted trades, 12 are puts, for a total amount of $589,675 and 5, calls, for a total amount of $608,250.
在所有已發現的交易中，有12筆是看跌期權，總額爲589,675美元，5筆看漲期權，總額爲608,250美元。
Projected Price Targets
預計價格目標
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $10.0 and $15.0 for Iovance Biotherapeutics, spanning the last three months.
在評估了交易量和未平倉合約之後，很明顯，主要市場走勢者將注意力集中在Iovance Biotherapeutics在過去三個月的10.0美元至15.0美元之間的價格區間上。
Insights into Volume & Open Interest
對交易量和未平倉合約的見解
In today's trading context, the average open interest for options of Iovance Biotherapeutics stands at 1138.5, with a total volume reaching 11,833.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Iovance Biotherapeutics, situated within the strike price corridor from $10.0 to $15.0, throughout the last 30 days.
在當今的交易背景下，Iovance Biotherapeutics期權的平均未平倉合約爲1138.5張，總成交量達到11,833.00。隨附的圖表描繪了過去30天中Iovance Biotherapeutics高價值交易的看漲和看跌期權交易量以及未平倉合約的變化，這些交易位於行使價走廊內，從10.0美元到15.0美元。
Iovance Biotherapeutics Option Volume And Open Interest Over Last 30 Days
Iovance Biotherapeutics 過去 30 天的期權交易量和未平倉合約
Largest Options Trades Observed:
觀察到的最大期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVA | CALL | SWEEP | BEARISH | 12/20/24 | $2.55 | $2.45 | $2.45 | $14.00 | $220.5K | 8 | 602 |
| IOVA | CALL | TRADE | BEARISH | 12/20/24 | $2.55 | $2.4 | $2.4 | $14.00 | $144.0K | 8 | 602 |
| IOVA | CALL | SWEEP | BULLISH | 06/21/24 | $2.5 | $2.3 | $2.5 | $10.00 | $125.0K | 3.0K | 20 |
| IOVA | PUT | SWEEP | BULLISH | 09/20/24 | $4.2 | $4.0 | $4.0 | $15.00 | $78.8K | 578 | 197 |
| IOVA | PUT | SWEEP | BEARISH | 09/20/24 | $1.55 | $1.4 | $1.55 | $10.00 | $74.7K | 854 | 231 |
| 符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IOVA | 打電話 | 掃 | 粗魯的 | 12/20/24 | 2.55 美元 | 2.45 美元 | 2.45 美元 | 14.00 美元 | 220.5 萬美元 | 8 | 602 |
| IOVA | 打電話 | 貿易 | 粗魯的 | 12/20/24 | 2.55 美元 | 2.4 美元 | 2.4 美元 | 14.00 美元 | 144.0 萬美元 | 8 | 602 |
| IOVA | 打電話 | 掃 | 看漲 | 06/21/24 | 2.5 美元 | 2.3 美元 | 2.5 美元 | 10.00 美元 | 125.0K | 3.0K | 20 |
| IOVA | 放 | 掃 | 看漲 | 09/20/24 | 4.2 美元 | 4.0 美元 | 4.0 美元 | 15.00 美元 | 78.8 萬美元 | 578 | 197 |
| IOVA | 放 | 掃 | 粗魯的 | 09/20/24 | 1.55 美元 | 1.4 美元 | 1.55 美元 | 10.00 美元 | 74.7 萬美元 | 854 | 231 |
About Iovance Biotherapeutics
關於 Iovance 生物療法
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Iovance Biotherapeutics Inc是一家處於臨床階段的生物製藥公司，通過利用人體免疫系統識別和摧毀各種癌細胞的能力，使用針對每位患者的個性化療法，開創了一種治療癌症的變革性方法。該公司正在爲第一種治療實體瘤的自體T細胞療法可能獲得美國監管部門的批准和商業化做準備。其目標是成爲創新、開發和提供針對實體瘤癌患者的腫瘤浸潤淋巴細胞（TIL）療法的領導者。
In light of the recent options history for Iovance Biotherapeutics, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鑑於Iovance Biotherapeutics最近的期權歷史，現在應該將重點放在公司本身上。我們的目標是探索其目前的表現。
Where Is Iovance Biotherapeutics Standing Right Now?
Iovance Biotherapeutics 現在處於什麼位置？
- Currently trading with a volume of 11,609,305, the IOVA's price is down by -17.77%, now at $11.06.
- RSI readings suggest the stock is currently may be approaching oversold.
- Anticipated earnings release is in 88 days.
- IOVA目前的交易量爲11,609,305美元，其價格下跌了-17.77％，目前爲11.06美元。
- RSI讀數表明，該股目前可能已接近超賣。
- 預計收益將在88天后發佈。
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Iovance Biotherapeutics with Benzinga Pro for real-time alerts.
交易期權涉及更大的風險，但也提供了更高利潤的潛力。精明的交易者通過持續的教育、戰略貿易調整、利用各種指標以及隨時關注市場動態來降低這些風險。使用Benzinga Pro了解Iovance Biotherapeutics的最新期權交易，以獲取實時警報。